Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

IntriCon Corporation (IIN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.33+0.16 (+1.05%)
At close: 04:00PM EST
15.33 0.00 (0.00%)
After hours: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close15.17
Open15.63
Bid15.33 x 1400
Ask15.67 x 1200
Day's Range15.26 - 15.94
52 Week Range14.89 - 28.16
Volume41,955
Avg. Volume33,144
Market Cap139.078M
Beta (5Y Monthly)1.30
PE Ratio (TTM)1,179.23
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateSep 12, 2001
1y Target EstN/A
  • GlobeNewswire

    Intricon to Present at the Virtual 2021 Stifel Healthcare Conference

    ARDEN HILLS, Minn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced that Scott Longval, Intricon’s President and Chief Executive Officer, will present at the upcoming Virtual 2021 Stifel Healthcare Conference. Intricon is scheduled to present on Monday, November 15, 20

  • GlobeNewswire

    Intricon Reports Third Quarter 2021 Results

    ARDEN HILLS, Minn., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its third quarter ended September 30, 2021. Third Quarter 2021 Highlights: Revenue of $31.1 million, a 13.5% increase compared to the prior year periodGross profit margin of 23.1%

  • GlobeNewswire

    Intricon Announces CFO Departure and Preliminary Third Quarter 2021 Revenue

    ARDEN HILLS, Minn., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, announced today that Ellen Scipta has stepped down from her position as Chief Financial Officer, effective October 29, 2021. Annalee Lutgen, current Treasurer and Director of Finance, will serve as interim Chief Finan

Advertisement
Advertisement